Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease
Open Access
- 25 November 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 4 (6), 368-375
- https://doi.org/10.1093/ndtplus/sfr140
Abstract
Diabetic nephropathy is the most common aetiology of end-stage kidney disease (ESKD). Strict glycaemic control reduces the development and progression of diabetes-related complications, and there is evidence that improved metabolic control improves outcomes in diabetic subjects with advanced chronic kidney disease (CKD). Glycaemic control in people with kidney disease is complex. Changes in glucose and insulin homeostasis may occur as a consequence of loss of kidney function and dialysis. The reliability of measures of long-term glycaemic control is affected by CKD and the accuracy of glycated haemoglobin (HbA1c) in the setting of CKD and ESKD is questioned. Despite the altered character of diabetes in CKD, current guidelines for diabetes management are not specifically adjusted to this patient group. The validity of indicators of longer term glycaemic control has been the focus of increased recent research. This review discusses the current understanding of commonly used indicators of metabolic control (HbA1c, fructosamine, glycated albumin) in the setting of advanced CKD (Stages 4 and 5, glomerular filtration rate 2).Keywords
This publication has 89 references indexed in Scilit:
- HbA1c and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) studyDiabetologia, 2010
- Glycemic Control and Extended Hemodialysis Survival in Patients with Diabetes MellitusClinical Journal of the American Society of Nephrology, 2010
- Association Between Iron Deficiency and A1C Levels Among Adults Without Diabetes in the National Health and Nutrition Examination Survey, 1999–2006Diabetes Care, 2010
- Assessing Glycemic Control in Maintenance Hemodialysis Patients With Type 2 DiabetesDiabetes Care, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)Kidney International, 2003
- Global and societal implications of the diabetes epidemicNature, 2001
- Influence of glycemic control and hypertension on urinary microprotein excretion in non-insulin-dependent diabetes mellitusJournal of Diabetic Complications, 1991